Table 3.
Biomarker | No infection | Viral | Suspected bacterial without shock | Documented bacterial without shock | Bacterial with shock | Culture-negative septic shock | p-valuea |
---|---|---|---|---|---|---|---|
PCT (ng/mL)b | 0.22 (0.05–1.70) | 0.33 (0.07–1.45) | 1.51 (0.41–4.04) | 0.91 (0.10–10.80) | 7.16 (2.21–42.28) | 3.22 (0.36–24.93) | <0.001 |
CRP (mg/dL)c | 1.9 (0.5–6.8) | 1.4 (0.6–3.9) | 5.2 (2.4–15.5) | 5.0 (2.3–15.8) | 18.3 (7.4–31.7) | 6.2 (1.8–21.5) | <0.001 |
WBC (thou/μL)d | 12.3 (8.1–16.0) | 11.6 (8.6–15.0) | 13.7 (9.5–18.6) | 14.8 (10.6–18.5) | 11.6 (2.8–18.8) | 12.7 (8.3–20.4) | 0.25 |
ANC (thou/μL)e | 8.3 (4.1–12.0) | 7.6 (5.1–12.1) | 9.4 (6.3–14.7) | 9.8 (5.9–14.0) | 7.6 (0.4–15.4) | 9.0 (4.6–13.7) | 0.08 |
% Immaturef | 0 (0–1.0) | 0 (0–4.0) | 0.5 (0–8.2) | 0 (0–0.3) | 0 (0–14.0) | 2 (0–14.0) | <0.001 |
Data presented as median (IQR).
p-value calculated as test of trend across categories. For the purposes of test of trend calculation, suspected bacterial infection without shock and documented bacterial infection without shock were combined into a single category (bacterial infection without shock), and bacterial infection with shock and culture-negative septic shock were combined into a single category (shock).
PCT available from all 646 patients
CRP available from 546 patients
WBC available from 633 patients
ANC available from 609 patients
% Immature available from 605 patients